Platelet-rich Plasma for Menical Tear

Last updated: July 29, 2019
Sponsor: University of Malaga
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04040283
UMalaga21
  • Ages 18-60
  • All Genders

Study Summary

Meniscal injuries are a common pathology among athletes, and have an impact on the daily or sporting practice of patients. Surgical approach implies sometimes heavy consequences. Platelet-rich-plasma (PRP) has been shown to be effective in accelerating wound healing and tissue regeneration in orthopedic and oral surgery. This clinical trial aims to investigate the safety and efficacy of intraarticular and periferal PRP injection in patients with stable meniscal injury. The pre- and post-interventional clinical outcomes will be compared.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Skeletally mature patients 18-70 years of age

  • With diagnosis of meniscus injury

  • Single tear of the medial and/or lateral meniscus

  • With no indication of meniscus repair surgery

Exclusion

Exclusion Criteria:

  • Prior history of multiple ligaments injury, associated significant ligamentinstability: Grade III MCL, Grade III PCL, or ACL deficient knee

  • Prior history of knee surgery

  • Discoid meniscus

  • Osteoarthritic changes (Kellgren Lawrence scale >2)

  • Inflammatory diseases (i.e. rheumatoid arthritis)

  • Underlying bleeding disorder or coagulopathy

  • Concominant chondral defects (> 2 ICRS)

  • Cancer patients

  • Pregnancy

  • Patients who will not cooperate with six-month followup

Study Design

Total Participants: 15
Study Start date:
January 01, 2014
Estimated Completion Date:
November 30, 2019

Connect with a study center

  • Ivan Medina-Porqueres

    Malaga,
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.